genetics-icon
Genetics

Innovative solutions that empower researchers, from ALS to fragile X syndrome.

Learn more about our Genetics portfolio
oncology-icon
Oncology

Solving complex molecular challenges, from leukemia to solid tumors.

Learn more about our Oncology portfolio
cdx-icon
MolecularDx Controls

The gold standard for molecular quality controls.

Learn more about our custom offerings
Spotlight

Asuragen Launches New Kit to Enable Broader Coverage of Gene Variants Linked to Cystic Fibrosis

CFTR testing kit with streamlined workflow delivers reliable results in less than five hours

Learn More
Spotlight

Asuragen Announces Launch of AmplideX® PCR/CE SMN1/2 Plus Kit

The AmplideX® PCR/CE SMN1/2 Plus Kit is a clinical research tool providing the most comprehensive analysis of SMN1 and SMN2 currently available from a commercial kit.

Learn more
Spotlight

Asuragen Expands Genetic Portfolio with Launch of AmplideX® PCR/CE HTT Kit

The AmplideX® PCR/CE HTT Kit is a simple, robust, and reliable test for the detection of CAG trinucleotide repeats within the HTT gene, aberrations which are associated with the development of Huntington’s Disease (HD).

Read more
Spotlight

Asuragen Develops Armored RNA Quant® SARS-CoV-2 Control

Asuragen, Inc has developed an Armored RNA Quant® SARS-CoV-2 Control for use in developing assays in response to the COVID-19 pandemic.

Learn more about our custom control offerings

The Latest from Asuragen

Looking Beyond Copy Number: Broad SMN1 and SMN2 profiling in under four hours with the AmplideX® PCR/CE SMN1/2 Plus Kit
Press Release
Pacific Biosciences and Asuragen Collaborate to Develop Assays for Carrier Screening and other Applications Based on SMRT Sequencing Technology and AmplideX PCR Chemistry
Press Release
Asuragen Develops Armored RNA Quant® SARS-CoV-2 Control
Press Release
Asuragen Partners with Wave Life Sciences to Develop Companion Diagnostics for Huntington’s Disease
Back To
Top